内科学
载脂蛋白B
帕金森病
甘油三酯
医学
内分泌学
载脂蛋白E
血脂
脂蛋白
逻辑回归
痴呆
血脂谱
生物标志物
胃肠病学
胆固醇
疾病
化学
生物化学
作者
Xiao Deng,Seyed Ehsan Saffari,Samuel Yong‐Ern Ng,Nicole Shuang Yu Chia,Jayne Yi Tan,Xinyi Choi,Dede Liana Heng,Zheyu Xu,Kay Yaw Tay,Wing Lok Au,Nan Liu,Adeline Su Lyn Ng,Eng‐King Tan,Louis Tan
出处
期刊:Journal of Parkinson's disease
[IOS Press]
日期:2022-09-02
卷期号:12 (6): 1937-1943
被引量:4
摘要
Lipid biomarkers have potential neuroprotective effects in Parkinson's disease (PD) and there is limited evidence in the field.This study aims to investigate the association between comprehensive blood lipid biomarkers and PD.A total of 205 PD patients and 102 non-PD subjects were included from Early Parkinson's disease Longitudinal Singapore (PALS) cohort. We investigated 6 serum lipid biomarkers including total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), apolipoprotein A1 (Apo A1), low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B (Apo B). PD patients were further classified into mild cognitive impairment (MCI) and normal cognition (NC) subgroups. We conducted a cross-sectionals study to examine the association between lipids and PD and further explored the relationship between lipids and PD-MCI.PD patients had significantly lower level of lipid panel including TC, TG, HDL-C, Apo A1, LDL-C, and Apo B (all p < 0.05). TC, TG, Apo A1, and Apo B levels were independent protective factors (p < 0.05) for PD in the logistic regression model. PD-MCI group had significantly higher mean TC, TG, and Apo A1 levels compared to PD-NC group. Higher TC, TG, and Apo A1 levels were independent risk factors (p < 0.05) for PD-MCI.We demonstrated that PD patients had significantly lower levels of lipid biomarkers while PD-MCI patients had higher levels of TC, TG, and Apo A1. TC, TG, and Apo A1 may be useful biomarkers for PD-MCI.
科研通智能强力驱动
Strongly Powered by AbleSci AI